1.149USD-0.09%Mkt Cap: 15.85M USDP/E: —Last update: 2026-05-26
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap15.85M USD
Enterprise Value12.32M USD
Revenue (TTM)225.00K USD
Gross Profit-4.84M USD
Net Income (TTM)-8.83M USD
Revenue/Share0.0180 USD
Last Price1.149 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees10
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS19188J4094
Valuation
P/E (Trailing)—
P/E (Forward)-1.77
PEG—
EV/EBITDA-1.37
EV/Revenue54.75
P/S69.24
P/B2.46
EPS (TTM)-0.72
EPS (Forward)-0.64
52W Range
0.860016% of range2.670
52W High2.670 USD
52W Low0.8600 USD
Profitability
Gross Margin0.00%
Oper. Margin-1047.11%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-139.49%
ROA-90.93%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.19M USD
CapEx (TTM)12.00K USD
FCF Margin-1961.89%
FCF Yield-27.84%
Net Debt-3.26M USD
Net Debt/EBITDA0.36
Balance Sheet
Debt/Equity0.24
Current Ratio2.66
Quick Ratio2.44
Book Value/Sh0.4590 USD
Cash/Share0.3400 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 24, 2018
Splits
Last Split1:12
Split DateOct 11, 2022
Analyst Consensus
Rating—
Target (Mean)8.000 USD
Target Range6.000 USD – 10.00 USD
# Analysts3
Ownership
Shares Out.13.79M
Float9.12M
Insiders25.44%
Institutions5.63%
Short Interest
Short Ratio0.1d
Short % Float6.93%
Short % Out.4.25%
Shares Short586.42K
Short (prev mo.)148.91K
Technical
SMA 501.280 (-10.3%)
SMA 2001.187 (-3.2%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)178.93K
Avg Vol (10d)124.00K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—